Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC
Financial strength (30%)
59/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$134.3M
Total Revenue
$296.5M
Total Expenses
$-2,870,674
Net Assets
1178
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
89.1%
Fundraising Efficiency
N/A
Operating Reserve
-0.12x
Liability-to-Asset
118.8%
Revenue Diversification
98.5%
Executive Compensation
$6.7M
Compared with Peers
FY 2023
Compared with 42 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
89.1% | 86.7% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.9% | 9.1% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.1% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-0.1 mo | 5.3 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
118.8% | 42.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.5% | 95.2% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
8.7% | 1.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
17.4% | 10.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-120.7% | 0.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $134.3M | $296.5M | $-2,870,674 | 89.1% | 1178 |
| 2022 | $123.5M | $252.5M | $3.7M | 88.7% | 1045 |
| 2021 | $113.7M | $238.7M | N/A | — | 941 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.